Clinical and economic impact of common multidrug-resistant gram-negative bacilli - Wikidata - wikimedia - TriplyDB

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

http://www.wikidata.org/entity/Q36482801

about

Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses Antibacterial Discovery and Development: From Gene to Product and Back Adult calcaneal osteitis: incidence, etiology, diagnostics and therapy Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa Regulation of Pseudomonas aeruginosa Virulence by Distinct Iron Sources Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii Anthelmintic Effect of Biocompatible Zinc Oxide Nanoparticles (ZnO NPs) on Gigantocotyle explanatum, a Neglected Parasite of Indian Water Buffalo The Effect of Infection Control Nurses on the Occurrence of Pseudomonas aeruginosa Healthcare-Acquired Infection and Multidrug-Resistant Strains in Critically-Ill Children Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Hospital epidemiology and infection control in acute-care settings.Newer antibacterial drugs for a new century.Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces.Multidrug resistant acinetobacter.Classification of 17 newly isolated virulent bacteriophages of Pseudomonas aeruginosa.Uptake of polymyxin B into renal cells Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.Extensively Drug-Resistant Klebsiella pneumoniae Causing Nosocomial Bloodstream Infections in China: Molecular Investigation of Antibiotic Resistance Determinants, Informing Therapy, and Clinical Outcomes.Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010.Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting.Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock Antimicrobial Resistance in Pseudomonas sp. Causing Infections in Trauma Patients: A 6 Year Experience from a South Asian Country.Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship.Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals

P2860

Q26751621-30A110C3-07C5-4963-AEE6-BAAB5FA31E2C Q26781236-F601ED28-E85E-40B0-AF17-61C6FAFB1F9C Q26784492-0750D7A8-28B9-46B7-AC64-CE9F8DF94540 Q26860304-06E34D52-985C-4E4F-B999-647022841451 Q27000458-5EBA3B44-E13E-45AB-A215-891DC869744F Q27024893-4DD0EE76-F9E6-4417-A923-067539DF4434 Q27026917-D5A916D6-6126-4646-AA2B-E7A1D92ACF8D Q27666204-9AB6A35C-B839-43C6-994E-117AB5FAEC7E Q28066690-75C1594F-1C53-4A9C-AE9C-B348D06AB4C2 Q28299749-595E2748-4FBE-4D43-8154-A5A5AC0AB196 Q28484243-E196973B-DAA1-4285-B856-DFA8C5F8D557 Q28546593-6D881D6B-93E3-409B-83A2-E586B67AB50C Q28551240-C4BD6E38-BB4F-4C12-B9C2-8429A574A63B Q29616084-E4967F7A-BE6B-45B2-AB33-1AEF1CEEE7F7 Q30429049-1876B985-3DB6-4126-8EA7-FC46B8CB5A8D Q30433333-C18ED6CF-D4E9-499D-8966-95DC3CFB566E Q33575730-DC275D8D-FD21-49C2-A517-D3C4FFBE36FF Q33623048-5FC241A8-C239-4D20-843A-DA87FB58BA66 Q33634460-E1259D64-B04E-44B8-9D82-EA6443DD23F5 Q33686050-EF96DA46-79F2-410A-9BA7-AB05CC365291 Q33711902-805D9B97-2E35-45BC-8BB5-2D549F4F2D3D Q33746414-608FDE60-D623-46A7-9250-B336926C162E Q33798384-8CFC554D-ECEE-4D5E-A1CF-2EBB266D69C5 Q33853131-CDFC46B8-FB59-4A62-8238-0BDBF349F01F Q33857498-7793865B-CF72-48F3-A183-2B5DF86B251F Q33900038-06FA3577-1DB8-4354-8525-E29EFD624B6B Q33997664-27BEDDFF-77A7-47A8-82AD-A57265676777 Q34026818-6AC6A1E2-0823-419C-8FAD-6DD3E1B7D2E7 Q34044909-0155BECE-BE6D-4442-B037-4CCEA25BABF0 Q34108708-D435DD5A-DB72-472E-8887-CC322EA18DEB Q34150900-27E24D37-7DB2-41D7-AECD-E1669C68ABB0 Q34296375-053FFC07-FB39-42F3-99AE-033D9F6990A8 Q34446914-AE6AE605-B85B-4B02-9D06-DD42E1F8C1E4 Q34483679-71963D91-A05B-4CA5-BBE2-B08C075EC033 Q34564797-EC5E62F6-04E4-4B99-8F9A-EC8185E50F8F Q34597601-712C1286-25C6-4024-8CD2-5D74479D9B13 Q34645044-812B101B-3418-4C06-92EE-11459F19875F Q34699065-895A4B7E-494B-4B95-8E2B-FBD0BF733D09 Q34759062-CE490A91-5426-425B-8B3F-2FC52B72B751 Q34800300-533959DE-1E08-4C20-AE9F-71593AB33CDF

P2860

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

http://www.wikidata.org/entity/Q36482801

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@ast

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@en

type

label

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@ast

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@en

prefLabel

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@ast

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@en

P1433

Q36482801-BAE72AC1-D9CE-415F-B385-46316F5FF759

P1476

Q36482801-F685DA70-B67F-4602-A4EF-9DFBE42EFDAD

P2093

Q36482801-2F90C895-C190-4413-9DCD-ABCD0016985D

Q36482801-41801AFC-C328-4DDF-BB1B-AC00B9A6A0C7

Q36482801-4AB0F54E-4A9D-4C69-90D7-E777C539FF6E

Q36482801-8B0300E9-C61F-4A40-8911-6091C1C251ED

P2860

Q36482801-02535C8D-B518-4406-BA41-4A3B55FEBC9C

Q36482801-051AF840-D91A-40C3-861D-662225CD31C5

Q36482801-09CD5A87-504E-46B0-8019-82A5F62D2148

Q36482801-0F2D9716-1258-4509-AC8E-5D4D2FDB86CB

Q36482801-0FBDC977-4AD5-419C-A341-519384BE8BD7

Q36482801-12490E5F-8579-420D-A71C-92C5A46232DD

Q36482801-1427AF49-0419-4A8A-A7E5-673EA73CFC04

Q36482801-177D5A35-4192-4DF2-A021-C1AAF9698760

Q36482801-273D7A41-5760-4B96-A1B7-2EFD242E3FC7

Q36482801-28552A0A-3F3B-4F2D-91F6-E4CDE2745F74

P304

Q36482801-0CFFAD73-1A03-4720-B882-F56CBDA8EB2B

P31

Q36482801-CB9AC675-06CB-49FD-A624-3F5835AC0459

P356

Q36482801-0C9AAC6E-CC54-49DA-99F4-0DA144642C5E

P407

Q36482801-29DE5C14-B58E-4A5E-BED2-6BF404F7A3D6

P433

Q36482801-47873DDA-A9D4-4E43-AC79-A692631CF294

P478

Q36482801-308DE85B-1768-47C1-86F3-58253D31DF78

P50

Q36482801-2869E3F7-A31D-430C-B63C-7F49D0547D93

P577

Q36482801-4197CDD0-D738-4378-8395-C820962ABF45

P698

Q36482801-CC915E9F-0FB7-46D4-9152-B2C63C3F3965

P921

Q36482801-20B541F7-A3C0-4536-BE39-0AFCF8A6D9A8

Q36482801-D98151C4-25A5-4B6E-B646-A9F4261E44F6

P932

Q36482801-3A88379E-A1D4-49AE-8519-8911E3675240

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

@en

P2093

Dominique L Monnet

http://www.w3.org/2001/XMLSchema#string

Otto Cars

http://www.w3.org/2001/XMLSchema#string

ReAct-Action on Antibiotic Resistance

http://www.w3.org/2001/XMLSchema#string

Yehuda Carmeli

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of the development of antibiotic resistance in Staphylococcus aureus

Extended-spectrum beta-lactamases: a clinical update

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

Tigecycline: what is it, and where should it be used?

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Metallo-beta-lactamases: the quiet before the storm?

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

P304

813-821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01169-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Christian Giske

P577

2007-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18070961

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

multiple drug resistance

P932

2258516

http://www.w3.org/2001/XMLSchema#string